GOLDMAN SACHS GROUP INC

Position in ASND — Ascendis Pharma A/S

CIK 886982 NEW YORK, NY

Back to ASND Full portfolio

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$129,505,095

+$2,264,148 QoQ

Shares Held

566,192

-5.1% QoQ

Ownership

0.863%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Sep 30, 2025

CallValue

$1,650,123

CallShares

8,300

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ASND ranks #18 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

All Filings in ASND

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$129,505,095	566,192	-5.1%	Shares	Defined	2026-05-15
2025-12-31	$127,240,947	596,703	+7089.2%	Shares	Defined	2026-03-25
2025-09-30	$1,650,123	8,300	-98.7%	Call	Defined	2025-11-14
2025-09-30	$129,825,315	653,012	+6179.0%	Shares	Defined	2025-11-14
2025-06-30	$1,795,040	10,400	-98.1%	Call	Defined	2025-08-14
2025-06-30	$92,908,335	538,287	-8.1%	Shares	Defined	2025-08-14
2025-03-31	$91,268,654	585,581	+10.4%	Shares	Defined	2025-06-27
2024-12-31	$73,022,508	530,417	+8.2%	Shares	Defined	2025-02-11
2024-09-30	$73,214,307	490,351	+989.7%	Shares	Defined	2024-11-14
2024-09-30	$6,718,950	45,000	-89.3%	Call	Defined	2024-11-14
2024-06-30	$57,491,125	421,551	+4532.4%	Shares	Defined	2024-08-13
2024-06-30	$1,241,058	9,100	-97.9%	Call	Defined	2024-08-13
2024-03-31	$66,075,197	437,092	+3.4%	Shares	Defined	2024-05-15
2023-12-31	$53,258,461	422,854	+3.1%	Shares	Defined	2024-05-14
2023-09-30	$38,389,871	409,973	+3.2%	Shares	Defined	2024-05-15
2023-06-30	$35,440,371	397,091	+694.2%	Shares	Defined	2024-05-14
2023-03-31	$5,361,000	50,000	-98.0%	Put	Defined	2024-05-14
2023-03-31	$273,212,106	2,548,145	+9337.6%	Shares	Defined	2024-05-14
2023-03-31	$2,894,940	27,000	-98.9%	Call	Defined	2024-05-14
2022-12-31	$307,708,000	2,519,512	+38074.4%	Shares	Defined	2024-05-14
2022-12-31	$806,058	6,600	-91.2%	Call	Defined	2024-05-14
2022-09-30	$7,744,500	75,000	-97.4%	Call	Defined	2024-05-14
2022-09-30	$295,161,481	2,858,430	-13.8%	Shares	Defined	2024-05-14
2022-06-30	$308,275,346	3,316,215	+89.0%	Shares	Defined	2024-05-14
2022-03-31	$205,903,190	1,754,458	+3024.3%	Shares	Defined	2022-05-16
2021-12-31	$7,554,666	56,156	+81.3%	Shares	Defined	2022-02-17
2021-09-30	$4,935,989	30,968	-79.9%	Shares	Defined	2022-01-20
2021-06-30	$20,281,195	154,171	+111.7%	Shares	Defined	2021-08-13
2021-03-31	$9,386,717	72,833	+5.4%	Shares	Defined	2021-05-17
2020-12-31	$11,526,999	69,115	+54.7%	Shares	Defined	2021-02-12
2020-09-30	$6,893,783	44,672	+123.4%	Shares	Defined	2020-11-13
2020-09-30	$3,086,400	20,000	0.0%	Put	Defined	2020-11-13
2020-09-30	$3,086,400	20,000	-61.3%	Call	Defined	2020-11-13
2020-06-30	$7,636,520	51,633	+16.2%	Shares	Defined	2020-08-12
2020-03-31	$5,004,613	44,442	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.